S

Schrodinger
D

SDGR

19.900
USD
1.07
(5.68%)
Market Closed
Volume
30,119
EPS
0
Div Yield
-
P/E
-8
Market Cap
1,453,464,021
Related Instruments
A
ALLO
0.07500
(5.45%)
1.45000 USD
B
BEAM
0.860
(4.88%)
18.490 USD
B
BLUE
-0.22000
(-4.18%)
5.04000 USD
C
CLLS
-0.03500
(-2.69%)
1.26500 USD
C
CRSP
1.090
(3.29%)
34.200 USD
E
EDIT
0.05500
(4.85%)
1.19000 USD
N
NTLA
0.65000
(9.77%)
7.30500 USD
R
RGEN
2.490
(1.94%)
131.030 USD
VRTX
VRTX
-1.36
(-0.28%)
483.38 USD
More
News

Title: Schrodinger

Sector: Healthcare
Industry: Health Information Services
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.